IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Sage Therapeutics, Inc.
Symbol: SAGE
Price: Last trade $41.34
Trade Date: 9/9
Shares: 3.63 million
Underwriter(s) J.P. Morgan, Goldman Sachs
Co Manager(s) Canaccord Genuity
Rating=Subscription Needed
Company: Healthcare Trust of America, Inc.
Symbol: HTA
Price: Last trade $34.64
Description: Re-offer $33.60-$33.95
Trade Date: 9/8
Shares: 3.5 million
Underwriter(s) Wells Fargo Securities, Jefferies, BMO Capital Markets
Rating=Subscription Needed
Company: Western Refining Logistics
Symbol: WNRL
Price: Last trade $24.26
Description: Re-offer range $22.32-$22.80
Trade Date: 9/8
Shares: 5.25 million
Underwriter(s) Barclays
Rating=Subscription Needed
Company: American Homes 4 Rent
Symbol: AMH
Price: Last trade $22.77
Description: Re-offer $21.50-$22.00
Trade Date: 9/8
Shares: 43.5 million
Underwriter(s) BofA Merrill Lynch
Rating=Subscription Needed
Company: Xenon Pharmaceuticals
Symbol: XENE
Price: Last trade $8.01
Description: Re-offer $7.50-$7.75
Trade Date: 9/8
Shares: 3.12 million
Underwriter(s) Jefferies, Stifel, Guggneheim Securities
Rating=Subscription Needed